Comparison between DATAMATICS TECHNOLOGIES IPO and DISHMAN PHARMACEUTICALS CHEMICALS IPO.
DATAMATICS TECHNOLOGIES IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while DISHMAN PHARMACEUTICALS CHEMICALS IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of DATAMATICS TECHNOLOGIES IPO is up to ₹113.30 Cr whereas the issue size of the DISHMAN PHARMACEUTICALS CHEMICALS IPO is up to ₹60.09 Cr. The final issue price of DATAMATICS TECHNOLOGIES IPO is ₹110.00 per share and of DISHMAN PHARMACEUTICALS CHEMICALS IPO is ₹175.00 per share.
| DATAMATICS TECHNOLOGIES IPO | DISHMAN PHARMACEUTICALS CHEMICALS IPO | |
|---|---|---|
| Face Value | ₹5 per share | ₹10 per share |
| Issue Price (Lower) | ₹101.00 per share | ₹155.00 per share |
| Issue Price (Upper) | ₹110.00 per share | ₹175.00 per share |
| Issue Price (Final) | ₹110.00 per share | ₹175.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | ||
| Fresh Issue Size | 85,00,000 shares | 34,33,500 shares |
| Fresh Issue Size (Amount) | up to ₹93.50 Cr | up to ₹60.09 Cr |
| OFS Issue Size | 18,00,000 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹19.80 Cr | up to ₹0.00 Cr |
| Issue Size Total | 1,03,00,000 shares | 34,33,500 shares |
| Issue Size Total (Amount) | up to ₹113.30 Cr | up to ₹60.09 Cr |
DATAMATICS TECHNOLOGIES IPO opens on Apr 12, 2004, while DISHMAN PHARMACEUTICALS CHEMICALS IPO opens on Mar 29, 2004. The closing date of DATAMATICS TECHNOLOGIES IPO and DISHMAN PHARMACEUTICALS CHEMICALS IPO is Apr 19, 2004, and Apr 07, 2004, respectively.
DATAMATICS TECHNOLOGIES IPO P/E ratio is 22.71, as compared to DISHMAN PHARMACEUTICALS CHEMICALS IPO P/E ratio of 12.64.
| DATAMATICS TECHNOLOGIES IPO | DISHMAN PHARMACEUTICALS CHEMICALS IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 92.83 | 99.994 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 68.95 | 74.99 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 22.71 | 12.64 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹446.30 Cr. | ₹240.34 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹4.84 | ₹13.84 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 24.88 | 30.74 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the DATAMATICS TECHNOLOGIES IPO Retail Individual Investors (RII) are offered 25,37,500 shares while in DISHMAN PHARMACEUTICALS CHEMICALS IPO retail investors are offered 25,37,500 shares. Qualified Institutional Buyers (QIB) are offered 50,75,000 shares in DATAMATICS TECHNOLOGIES IPO and 17,16,700 shares in DISHMAN PHARMACEUTICALS CHEMICALS IPO.
| DATAMATICS TECHNOLOGIES IPO | DISHMAN PHARMACEUTICALS CHEMICALS IPO | |
|---|---|---|
| Anchor Investor Reservation | 0 shares | 0 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 50,75,000 shares | 17,16,700 shares |
| NII | 25,37,500 shares | 8,58,400 shares |
| RII | 25,37,500 shares | 8,58,400 shares |
| Employee | 1,50,000 shares | 0 shares |
| Others | ||
| Total | 1,03,00,000 shares | 34,33,500 shares |
DATAMATICS TECHNOLOGIES IPO subscribed in total, whereas DISHMAN PHARMACEUTICALS CHEMICALS IPO subscribed .
